Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY 4.0Cells

IgA-Expressing Cells at the Human Ocular Surface and Reduced Tear IgA2 Abundance in Schirmer Strip Extracts from Patients with Dry Eye Disease and Primary Sjögren’s Syndrome

4 affiliations
  1. 1Functional and Clinical Anatomy, Institute of Anatomy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
  2. 2Department of Ophthalmology, Medical University of Graz, 8036 Graz, Austria
  3. 3Department of Translational Immunology, Department of Medicine 3—Rheumatology and Immunology, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinikum Erlangen, 91054 Erlangen, Germany
  4. 4Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinikum Erlangen, 91054 Erlangen, Germany

Abstract

This study investigated the distribution of IgA-expressing cells in human ocular tissues and IgA subclass profiles in Schirmer strip extracts from patients with dry eye disease (DED) and primary Sjögren’s syndrome (pSS). Immunofluorescence staining was performed on paraffin-embedded lacrimal gland, conjunctival, and corneal tissues from body donors. Independently, Schirmer strip extracts from healthy controls (n = 18), patients with DED (n = 75), and patients with pSS (n = 10) were analyzed. Total protein concentrations were determined using a bicinchoninic acid assay, while total IgA, IgA1, and IgA2 were quantified by ELISA and normalized to total protein. CD38+ and CD38− IgA-expressing cells were detected in the lacrimal gland and conjunctival stroma, with IgA1-expressing cells predominating over IgA2-expressing cells. No IgA-positive cells were detected in the examined corneal sections. Total protein concentrations were lower in pSS than in DED. Normalized IgA2 abundance was reduced in both DED and pSS compared with controls, while normalized total IgA was additionally reduced in pSS. Unnormalized extract concentrations showed broadly similar patterns. These independent findings demonstrate differences in recovered IgA subclass profiles, although differences in collection materials and patient characteristics preclude attributing these alterations exclusively to the underlying diseases.

Related

  1. Evidence consistency analysis of the effect of a low-FODMAP diet on the abundance of Bifidobacterium and Faecalibacterium prausnitzii in patients with irritable bowel syndrome
    Bingqian Cao, Li Zhou, Shouzhang Hu +1
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textMicrobiologyCrossrefEurope PMC
  2. Hyperphagia is prominent in adult patients with short bowel syndrome: A role for the colon?
    Salma Fourati, Brune de Dreuille, Joanna Bettolo +5
    Clinical NutritionPeer-reviewedLicence not statedFull text15 citedGeneral biologyHAL
  3. Autoantibodies from recovered Guillain-Barre syndrome patients exhibit altered effector functions that prevent subsequent neuron degeneration
    A. M. Rogers, J. L. McAlpine, X. Yang +9
    bioRxivPreprintCC BY-NCFull textImmunologybioRxiv
  4. 938 A spatially optimized long-acting gp100×CD3×albumin trispecific antibody enables durable antitumor immunity in gp100-expressing solid tumors
    Yi Yang, Xue Li, Yue Zhang +4
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  5. The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.
    Raimbault A, Itzykson R, Willems L +9
    Cytometry. Part B, Clinical cytometryPeer-reviewedLicence not statedFull text16 citedGeneral biologyGeneral medicineHAL
BibTeX
@article{schellekens2026igaexpressing,
  title = {{IgA-Expressing Cells at the Human Ocular Surface and Reduced Tear IgA2 Abundance in Schirmer Strip Extracts from Patients with Dry Eye Disease and Primary Sjögren’s Syndrome}},
  author = {Nils Schellekens and Jutta Horwath-Winter and Sophia Bittner and Wolfgang Schuh and Katharina Jüngert and Ingrid Zahn and Martin Schicht and Friedrich Paulsen},
  journal = {Cells},
  year = {2026},
  month = oct,
  doi = {10.3390/cells15211971},
  url = {https://www.mdpi.com/2073-4409/15/21/1971},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - IgA-Expressing Cells at the Human Ocular Surface and Reduced Tear IgA2 Abundance in Schirmer Strip Extracts from Patients with Dry Eye Disease and Primary Sjögren’s Syndrome
AU  - Nils Schellekens
AU  - Jutta Horwath-Winter
AU  - Sophia Bittner
AU  - Wolfgang Schuh
AU  - Katharina Jüngert
AU  - Ingrid Zahn
AU  - Martin Schicht
AU  - Friedrich Paulsen
PY  - 2026
DA  - 2026/10/29
JO  - Cells
DO  - 10.3390/cells15211971
UR  - https://www.mdpi.com/2073-4409/15/21/1971
AB  - This study investigated the distribution of IgA-expressing cells in human ocular tissues and IgA subclass profiles in Schirmer strip extracts from patients with dry eye disease (DED) and primary Sjögren’s syndrome (pSS). Immunofluorescence staining was performed on paraffin-embedded lacrimal gland, conjunctival, and corneal tissues from body donors. Independently, Schirmer strip extracts from healthy controls (n = 18), patients with DED (n = 75), and patients with pSS (n = 10) were analyzed. Total protein concentrations were determined using a bicinchoninic acid assay, while total IgA, IgA1, and IgA2 were quantified by ELISA and normalized to total protein. CD38+ and CD38− IgA-expressing cells were detected in the lacrimal gland and conjunctival stroma, with IgA1-expressing cells predominating over IgA2-expressing cells. No IgA-positive cells were detected in the examined corneal sections. Total protein concentrations were lower in pSS than in DED. Normalized IgA2 abundance was reduced in both DED and pSS compared with controls, while normalized total IgA was additionally reduced in pSS. Unnormalized extract concentrations showed broadly similar patterns. These independent findings demonstrate differences in recovered IgA subclass profiles, although differences in collection materials and patient characteristics preclude attributing these alterations exclusively to the underlying diseases.
SN  - 2073-4409
ER  -